Economic Evaluation of Dasatinib Compared To Nilotinib as Second Line Treatment of Chronic Myeloid Leukemia in Greece
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.257
https://www.valueinhealthjournal.com/article/S1098-3015(17)30591-0/fulltext
Title :
Economic Evaluation of Dasatinib Compared To Nilotinib as Second Line Treatment of Chronic Myeloid Leukemia in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30591-0&doi=10.1016/j.jval.2017.08.257
First page :
A443
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
236